Hba, S.; Ghaddar, S.; Wahnou, H.; Pinon, A.; El Kebbaj, R.; Pouget, C.; Sol, V.; Liagre, B.; Oudghiri, M.; Limami, Y.
Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles. Pharmaceutics 2023, 15, 2718.
https://doi.org/10.3390/pharmaceutics15122718
AMA Style
Hba S, Ghaddar S, Wahnou H, Pinon A, El Kebbaj R, Pouget C, Sol V, Liagre B, Oudghiri M, Limami Y.
Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles. Pharmaceutics. 2023; 15(12):2718.
https://doi.org/10.3390/pharmaceutics15122718
Chicago/Turabian Style
Hba, Soufyane, Suzan Ghaddar, Hicham Wahnou, Aline Pinon, Riad El Kebbaj, Christelle Pouget, Vincent Sol, Bertrand Liagre, Mounia Oudghiri, and Youness Limami.
2023. "Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles" Pharmaceutics 15, no. 12: 2718.
https://doi.org/10.3390/pharmaceutics15122718
APA Style
Hba, S., Ghaddar, S., Wahnou, H., Pinon, A., El Kebbaj, R., Pouget, C., Sol, V., Liagre, B., Oudghiri, M., & Limami, Y.
(2023). Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles. Pharmaceutics, 15(12), 2718.
https://doi.org/10.3390/pharmaceutics15122718
